Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ROYCE & ASSOCIATES LP | 02-08-2024 | 12-31-2023 | 860 | 10,827,293,014 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
XPEL INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
EMCORE CORP | COM NEW | 1352 | $385,528 | 788,400 | 0.00 | 0.00 | 0 | 0.00 | 12-31-2023 |
4D MOLECULAR THERAPEUTICS IN | COM | 1353 | $380,260 | 18,769 | 0.00 | 18,769 | +Inf | 12-31-2023 | |
ZYNEX INC | COM | Liquidated | $0 | 0 | 0.00 | 0.00 | -18,263 | -27.86 | 12-31-2023 |